REG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Trading Update

Mycelx TechnologiesAnnouncement

Thu 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250717:nRSQ3852Ra&default-theme=true

RNS Number : 3852R  MyCelx Technologies Corporation  17 July 2025

The information contained within this Announcement is deemed by MYCELX
Technologies Corporation to constitute inside information as stipulated under
the Market Abuse Regulation (EU) No. 596/2014 as it forms part
of UK domestic law by virtue of the European Union (Withdrawal) Act 2018
("MAR").

 

17 July 2025

 

MYCELX Technologies Corporation

("MYCELX" or the "Company")

 

Trading Update

 

MYCELX Technologies Corporation (AIM: MYX), the clean water and clean air
technology company, provides a trading update, which includes select financial
information from its unaudited H1 2025 results. The Company expects to release
its final unaudited results for H1 2025 in September 2025.

 

Financial update:

 

·     Revenue for the half year was ca. $1.7m, due to on-site delays in
the Nigeria project pushing the delivery and $5.5m of revenue recognition to
October 2025. The Company has received $3.9 million in milestone payments for
the project.

·      H1 revenues relate primarily to recurring media sales, paid
trials and a small equipment sale.

·    H2 revenue is expected to include ca. $7.0m of project revenue from
Nigeria REGEN and Middle East EOR projects, plus an increased rate of
recurring media sales, PFAS project revenue and another small equipment sale.

·    The Company remains on track to meet its current financial guidance
for FY 2025 of revenue between $12.5m and $15.5m. 90% of revenue at the lower
end of the range is either already contracted or expected recurring media
sales.

·   As of 30 June 2025, cash and cash equivalents were $693,000 with a
further $600,000 of payments received shortly after H1 end.

 

Operational update:

 

·      PFAS

o  Awarded a contract with the Department of Defence in May 2025 to rent a
mobile PFAS treatment system treating AFFF.

o  Pre-treatment system was delivered for commissioning to re-start a
landfill leachate trial in early July.

 

·      Produced Water

o  Successfully completed an onshore trial in the U.S. Permian Basin with a
large oil producer which included both the MYCELX coalescer and REGEN
equipment.

o  On track to deliver second EOR project in the Middle East on Q4 2025.

 

·      Engaged energy industry veteran, Jim Summers, as advisor to the
Company with a particular focus on the growth of the Company's produced water
treatment business in the Permian Basin.

 

MYCELX has made notable progress in its strategy to establish its technology
as the next generation water treatment solution to manage the significant
water volumes produced in the Permian Basin today. The Company completed a
successful trial with a large oil producer which included both the MYCELX
coalescer and REGEN equipment and delivered higher quality, recycled water and
oil recovery volumes which would equate to millions of dollars in revenue per
year for the producer in addition to its production revenue.  The Company
views this as a springboard to future business in the Permian and U.S. onshore
in general as well as other regions globally where production reliability is
plagued with water quality issues. In the PFAS market the Company continued to
progress in the two PFAS verticals where activity is the most robust. The
Company secured a rental contract for a mobile PFAS treatment system at a U.S.
Department of Defence ('DoD') site that was delivered in early July and has an
open completion date due to treatment volume added post contract. The landfill
leachate trial has commenced after integration of the pre-treatment system and
success at this site could potentially lead to opportunities at similarly
operated landfills.

 

MYCELX recorded revenue of ca. $1.7 million in the first half of the year, due
to the Nigeria project experiencing on-site delays that has shifted delivery,
and therefore revenue recognition, to the second half of the year. H1 revenue
was generated primarily from recurring media sales, paid trials and a small
equipment sale. The second half of the year will include ca. $7.0 million of
project revenue from Nigeria REGEN and Middle East EOR projects, plus an
increased rate of recurring media sales, PFAS project revenue and another
small equipment sale. The Company remains on track to meet its current
financial guidance for FY 2025 of revenue between $12.5 million and $15.5
million. 90% of revenue at the lower end of the range is either already
contracted or expected recurring media sales. There are several other
potential opportunities which could influence 2025 revenue, with the final
outturn dependent on projects meeting delivery timelines.

 

As of 30 June 2025, the Company had cash and cash equivalents of $693,000.
However, MYCELX received payments of $600,000 in the first two weeks of July.
MYCELX continues to manage its working capital to support its future growth
ambitions and is considering other potential financing options to fund the
manufacture of capital equipment for specific opportunities in the Permian
Basin.

 

In March 2025, the Company engaged Jim Summers, an energy industry veteran, to
act as an Advisor to MYCELX. Mr. Summers was founder of H2O Midstream, a water
services company operating in the Permian Basin that was sold in 2024 for $230
million. In September 2024, he, along with other industry founders, started
GPC Infrastructure, a company delivering gas-powered energy solutions to data
centers. His insight and experience have been, and will continue to be,
invaluable to the Company as we grow our produced water treatment business in
the Permian Basin.

 

Connie Mixon, CEO, commented:

 

"Despite a project timing shift impacting first-half revenue recognition, we
have made critical operational progress in our key markets which we believe
will unlock substantial long-term revenue opportunities.

 

Looking ahead, we remain on track to deliver our full-year financial guidance,
supported by strong second-half revenue visibility, increasing adoption of our
solutions, and an expanding pipeline of opportunities. We continue to actively
manage our working capital while exploring other ways to finance the
manufacture of capital equipment for the Permian Basin. With the support of
industry expert Jim Summers and the dedication of our team, we are confident
in our ability to delivery meaningful growth and value to our stakeholders in
2025 and beyond."

 

 

For further information, please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                                                      Tel: +1 888 306 6843

 Kim Slayton, CFO

 Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

 Giles Balleny / Callum Davidson (Corporate Finance)                    Tel: +44 20 7220 0500

 Jamie Anderson (Corporate Broking)

 Jasper Berry / Michael Johnson (Sales)

 Celicourt Communications (Financial PR)

 Mark Antelme                                                           Tel: +44 20 7770 6424

 Jimmy Lea

 Charlie Denley-Myerson

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTPKABPOBKDQOD